ClearPoint Neuro (CLPT) Assets Growth (3y) (2014 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | ClearPoint Neuro | 375.84 Mn | 340.24 Mn | 7.76 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 22.96% |
| Dec 31, 2025 | 20.77% |
| Sep 30, 2025 | 1.49% |
| Jun 30, 2025 | 1.43% |
| Mar 31, 2025 | -21.33% |
| Dec 31, 2024 | -15.77% |
| Sep 30, 2024 | -16.36% |
| Jun 30, 2024 | -10.09% |
| Mar 31, 2024 | -10.28% |
| Dec 31, 2023 | 13.06% |
| Sep 30, 2023 | 26.13% |
| Jun 30, 2023 | 27.41% |
| Mar 31, 2023 | 28.67% |
| Dec 31, 2022 | 66.94% |
| Sep 30, 2022 | 62.77% |
| Jun 30, 2022 | 65.58% |
| Mar 31, 2022 | 100.83% |
| Dec 31, 2021 | 102.85% |
| Sep 30, 2021 | 99.30% |
| Jun 30, 2021 | 84.12% |
| Mar 31, 2021 | 81.85% |
| Dec 31, 2020 | 28.54% |
| Dec 31, 2019 | 17.24% |
| Sep 30, 2019 | 14.10% |
| Jun 30, 2019 | 27.23% |
| Mar 31, 2019 | -2.75% |
| Dec 31, 2018 | -7.53% |
| Sep 30, 2018 | 11.42% |
| Jun 30, 2018 | 13.82% |
| Mar 31, 2018 | 4.74% |
| Dec 31, 2017 | 1.26% |
| Dec 31, 2016 | -2.04% |
| Sep 30, 2016 | -1.80% |
| Jun 30, 2016 | -16.30% |
| Mar 31, 2016 | -13.97% |
| Dec 31, 2015 | 21.41% |
| Sep 30, 2015 | -5.75% |
| Jun 30, 2015 | 17.58% |
| Mar 31, 2015 | 38.19% |
| Dec 31, 2014 | 64.08% |